SG Americas Securities
FOLD

SG Americas Securities’s Amicus Therapeutics FOLD Stock Holding History

SG Americas Securities’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-50,000
Closed -$65K – 3347
2017
Q3 		$65K Buy
+50,000
New +$661K ﹤0.01% 3282

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

SG Americas Securities's FOLD Position: Q2 2026 in Review

SG Americas Securities sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 392,835 shares — an estimated $5.68M sold.

SG Americas Securities first reported a position in FOLD in Q2 2013 and held it in 36 quarters. The position peaked at $5.77M in Q2 2020. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • SG Americas Securities reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • SG Americas Securities sold 392,835 Amicus Therapeutics shares in Q2 2026, an estimated $5.68M.
  • SG Americas Securities first reported a position in Amicus Therapeutics in Q2 2013 and held it in 36 quarters.
  • SG Americas Securities's Amicus Therapeutics position peaked at $5.77M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.